Parametric Portfolio Associates LLC lifted its position in Heron Therapeutics, Inc. (NASDAQ:HRTX) by 22.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 160,332 shares of the biotechnology company’s stock after purchasing an additional 29,643 shares during the period. Parametric […]
